Nanocarrier-Based Vaccine Market
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Nanocarrier-Based Vaccine
1.2 Key Market Segments
1.2.1 Nanocarrier-Based Vaccine Segment by Type
1.2.2 Nanocarrier-Based Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Nanocarrier-Based Vaccine Market Overview
2.1 Global Market Overview
2.1.1 Global Nanocarrier-Based Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Nanocarrier-Based Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Nanocarrier-Based Vaccine Market Competitive Landscape
3.1 Global Nanocarrier-Based Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Nanocarrier-Based Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Nanocarrier-Based Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Nanocarrier-Based Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Nanocarrier-Based Vaccine Sales Sites, Area Served, Product Type
3.6 Nanocarrier-Based Vaccine Market Competitive Situation and Trends
3.6.1 Nanocarrier-Based Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Nanocarrier-Based Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Nanocarrier-Based Vaccine Industry Chain Analysis
4.1 Nanocarrier-Based Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Nanocarrier-Based Vaccine Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Nanocarrier-Based Vaccine Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Nanocarrier-Based Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Nanocarrier-Based Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Nanocarrier-Based Vaccine Price by Type (2019-2024)
7 Nanocarrier-Based Vaccine Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Nanocarrier-Based Vaccine Market Sales by Application (2019-2024)
7.3 Global Nanocarrier-Based Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Nanocarrier-Based Vaccine Sales Growth Rate by Application (2019-2024)
8 Nanocarrier-Based Vaccine Market Segmentation by Region
8.1 Global Nanocarrier-Based Vaccine Sales by Region
8.1.1 Global Nanocarrier-Based Vaccine Sales by Region
8.1.2 Global Nanocarrier-Based Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Nanocarrier-Based Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Nanocarrier-Based Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Nanocarrier-Based Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Nanocarrier-Based Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Nanocarrier-Based Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Emergent BioSolutions
9.1.1 Emergent BioSolutions Nanocarrier-Based Vaccine Basic Information
9.1.2 Emergent BioSolutions Nanocarrier-Based Vaccine Product Overview
9.1.3 Emergent BioSolutions Nanocarrier-Based Vaccine Product Market Performance
9.1.4 Emergent BioSolutions Business Overview
9.1.5 Emergent BioSolutions Nanocarrier-Based Vaccine SWOT Analysis
9.1.6 Emergent BioSolutions Recent Developments
9.2 Sanofi
9.2.1 Sanofi Nanocarrier-Based Vaccine Basic Information
9.2.2 Sanofi Nanocarrier-Based Vaccine Product Overview
9.2.3 Sanofi Nanocarrier-Based Vaccine Product Market Performance
9.2.4 Sanofi Business Overview
9.2.5 Sanofi Nanocarrier-Based Vaccine SWOT Analysis
9.2.6 Sanofi Recent Developments
9.3 GlaxoSmithKline Biologicals
9.3.1 GlaxoSmithKline Biologicals Nanocarrier-Based Vaccine Basic Information
9.3.2 GlaxoSmithKline Biologicals Nanocarrier-Based Vaccine Product Overview
9.3.3 GlaxoSmithKline Biologicals Nanocarrier-Based Vaccine Product Market Performance
9.3.4 GlaxoSmithKline Biologicals Nanocarrier-Based Vaccine SWOT Analysis
9.3.5 GlaxoSmithKline Biologicals Business Overview
9.3.6 GlaxoSmithKline Biologicals Recent Developments
9.4 Merck
9.4.1 Merck Nanocarrier-Based Vaccine Basic Information
9.4.2 Merck Nanocarrier-Based Vaccine Product Overview
9.4.3 Merck Nanocarrier-Based Vaccine Product Market Performance
9.4.4 Merck Business Overview
9.4.5 Merck Recent Developments
9.5 Pfizer
9.5.1 Pfizer Nanocarrier-Based Vaccine Basic Information
9.5.2 Pfizer Nanocarrier-Based Vaccine Product Overview
9.5.3 Pfizer Nanocarrier-Based Vaccine Product Market Performance
9.5.4 Pfizer Business Overview
9.5.5 Pfizer Recent Developments
9.6 Novartis
9.6.1 Novartis Nanocarrier-Based Vaccine Basic Information
9.6.2 Novartis Nanocarrier-Based Vaccine Product Overview
9.6.3 Novartis Nanocarrier-Based Vaccine Product Market Performance
9.6.4 Novartis Business Overview
9.6.5 Novartis Recent Developments
9.7 Moderna
9.7.1 Moderna Nanocarrier-Based Vaccine Basic Information
9.7.2 Moderna Nanocarrier-Based Vaccine Product Overview
9.7.3 Moderna Nanocarrier-Based Vaccine Product Market Performance
9.7.4 Moderna Business Overview
9.7.5 Moderna Recent Developments
10 Nanocarrier-Based Vaccine Market Forecast by Region
10.1 Global Nanocarrier-Based Vaccine Market Size Forecast
10.2 Global Nanocarrier-Based Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Nanocarrier-Based Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Nanocarrier-Based Vaccine Market Size Forecast by Region
10.2.4 South America Nanocarrier-Based Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Nanocarrier-Based Vaccine by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Nanocarrier-Based Vaccine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Nanocarrier-Based Vaccine by Type (2025-2030)
11.1.2 Global Nanocarrier-Based Vaccine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Nanocarrier-Based Vaccine by Type (2025-2030)
11.2 Global Nanocarrier-Based Vaccine Market Forecast by Application (2025-2030)
11.2.1 Global Nanocarrier-Based Vaccine Sales (Kilotons) Forecast by Application
11.2.2 Global Nanocarrier-Based Vaccine Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Nanocarrier-Based Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Nanocarrier-Based Vaccine Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Nanocarrier-Based Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Nanocarrier-Based Vaccine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Nanocarrier-Based Vaccine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanocarrier-Based Vaccine as of 2022)
Table 10. Global Market Nanocarrier-Based Vaccine Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Nanocarrier-Based Vaccine Sales Sites and Area Served
Table 12. Manufacturers Nanocarrier-Based Vaccine Product Type
Table 13. Global Nanocarrier-Based Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Nanocarrier-Based Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Nanocarrier-Based Vaccine Market Challenges
Table 22. Global Nanocarrier-Based Vaccine Sales by Type (Kilotons)
Table 23. Global Nanocarrier-Based Vaccine Market Size by Type (M USD)
Table 24. Global Nanocarrier-Based Vaccine Sales (Kilotons) by Type (2019-2024)
Table 25. Global Nanocarrier-Based Vaccine Sales Market Share by Type (2019-2024)
Table 26. Global Nanocarrier-Based Vaccine Market Size (M USD) by Type (2019-2024)
Table 27. Global Nanocarrier-Based Vaccine Market Size Share by Type (2019-2024)
Table 28. Global Nanocarrier-Based Vaccine Price (USD/Ton) by Type (2019-2024)
Table 29. Global Nanocarrier-Based Vaccine Sales (Kilotons) by Application
Table 30. Global Nanocarrier-Based Vaccine Market Size by Application
Table 31. Global Nanocarrier-Based Vaccine Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Nanocarrier-Based Vaccine Sales Market Share by Application (2019-2024)
Table 33. Global Nanocarrier-Based Vaccine Sales by Application (2019-2024) & (M USD)
Table 34. Global Nanocarrier-Based Vaccine Market Share by Application (2019-2024)
Table 35. Global Nanocarrier-Based Vaccine Sales Growth Rate by Application (2019-2024)
Table 36. Global Nanocarrier-Based Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Nanocarrier-Based Vaccine Sales Market Share by Region (2019-2024)
Table 38. North America Nanocarrier-Based Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Nanocarrier-Based Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Nanocarrier-Based Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Nanocarrier-Based Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Nanocarrier-Based Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 43. Emergent BioSolutions Nanocarrier-Based Vaccine Basic Information
Table 44. Emergent BioSolutions Nanocarrier-Based Vaccine Product Overview
Table 45. Emergent BioSolutions Nanocarrier-Based Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Emergent BioSolutions Business Overview
Table 47. Emergent BioSolutions Nanocarrier-Based Vaccine SWOT Analysis
Table 48. Emergent BioSolutions Recent Developments
Table 49. Sanofi Nanocarrier-Based Vaccine Basic Information
Table 50. Sanofi Nanocarrier-Based Vaccine Product Overview
Table 51. Sanofi Nanocarrier-Based Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Sanofi Business Overview
Table 53. Sanofi Nanocarrier-Based Vaccine SWOT Analysis
Table 54. Sanofi Recent Developments
Table 55. GlaxoSmithKline Biologicals Nanocarrier-Based Vaccine Basic Information
Table 56. GlaxoSmithKline Biologicals Nanocarrier-Based Vaccine Product Overview
Table 57. GlaxoSmithKline Biologicals Nanocarrier-Based Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. GlaxoSmithKline Biologicals Nanocarrier-Based Vaccine SWOT Analysis
Table 59. GlaxoSmithKline Biologicals Business Overview
Table 60. GlaxoSmithKline Biologicals Recent Developments
Table 61. Merck Nanocarrier-Based Vaccine Basic Information
Table 62. Merck Nanocarrier-Based Vaccine Product Overview
Table 63. Merck Nanocarrier-Based Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Merck Business Overview
Table 65. Merck Recent Developments
Table 66. Pfizer Nanocarrier-Based Vaccine Basic Information
Table 67. Pfizer Nanocarrier-Based Vaccine Product Overview
Table 68. Pfizer Nanocarrier-Based Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Pfizer Business Overview
Table 70. Pfizer Recent Developments
Table 71. Novartis Nanocarrier-Based Vaccine Basic Information
Table 72. Novartis Nanocarrier-Based Vaccine Product Overview
Table 73. Novartis Nanocarrier-Based Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Novartis Business Overview
Table 75. Novartis Recent Developments
Table 76. Moderna Nanocarrier-Based Vaccine Basic Information
Table 77. Moderna Nanocarrier-Based Vaccine Product Overview
Table 78. Moderna Nanocarrier-Based Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Moderna Business Overview
Table 80. Moderna Recent Developments
Table 81. Global Nanocarrier-Based Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 82. Global Nanocarrier-Based Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 83. North America Nanocarrier-Based Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 84. North America Nanocarrier-Based Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 85. Europe Nanocarrier-Based Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 86. Europe Nanocarrier-Based Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 87. Asia Pacific Nanocarrier-Based Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 88. Asia Pacific Nanocarrier-Based Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 89. South America Nanocarrier-Based Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 90. South America Nanocarrier-Based Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 91. Middle East and Africa Nanocarrier-Based Vaccine Consumption Forecast by Country (2025-2030) & (Units)
Table 92. Middle East and Africa Nanocarrier-Based Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 93. Global Nanocarrier-Based Vaccine Sales Forecast by Type (2025-2030) & (Kilotons)
Table 94. Global Nanocarrier-Based Vaccine Market Size Forecast by Type (2025-2030) & (M USD)
Table 95. Global Nanocarrier-Based Vaccine Price Forecast by Type (2025-2030) & (USD/Ton)
Table 96. Global Nanocarrier-Based Vaccine Sales (Kilotons) Forecast by Application (2025-2030)
Table 97. Global Nanocarrier-Based Vaccine Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Nanocarrier-Based Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Nanocarrier-Based Vaccine Market Size (M USD), 2019-2030
Figure 5. Global Nanocarrier-Based Vaccine Market Size (M USD) (2019-2030)
Figure 6. Global Nanocarrier-Based Vaccine Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Nanocarrier-Based Vaccine Market Size by Country (M USD)
Figure 11. Nanocarrier-Based Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Nanocarrier-Based Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Nanocarrier-Based Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Nanocarrier-Based Vaccine Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Nanocarrier-Based Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Nanocarrier-Based Vaccine Market Share by Type
Figure 18. Sales Market Share of Nanocarrier-Based Vaccine by Type (2019-2024)
Figure 19. Sales Market Share of Nanocarrier-Based Vaccine by Type in 2023
Figure 20. Market Size Share of Nanocarrier-Based Vaccine by Type (2019-2024)
Figure 21. Market Size Market Share of Nanocarrier-Based Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Nanocarrier-Based Vaccine Market Share by Application
Figure 24. Global Nanocarrier-Based Vaccine Sales Market Share by Application (2019-2024)
Figure 25. Global Nanocarrier-Based Vaccine Sales Market Share by Application in 2023
Figure 26. Global Nanocarrier-Based Vaccine Market Share by Application (2019-2024)
Figure 27. Global Nanocarrier-Based Vaccine Market Share by Application in 2023
Figure 28. Global Nanocarrier-Based Vaccine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Nanocarrier-Based Vaccine Sales Market Share by Region (2019-2024)
Figure 30. North America Nanocarrier-Based Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Nanocarrier-Based Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Nanocarrier-Based Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Nanocarrier-Based Vaccine Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Nanocarrier-Based Vaccine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Nanocarrier-Based Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Nanocarrier-Based Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Nanocarrier-Based Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Nanocarrier-Based Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Nanocarrier-Based Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Nanocarrier-Based Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Nanocarrier-Based Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Nanocarrier-Based Vaccine Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Nanocarrier-Based Vaccine Sales Market Share by Region in 2023
Figure 44. China Nanocarrier-Based Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Nanocarrier-Based Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Nanocarrier-Based Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Nanocarrier-Based Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Nanocarrier-Based Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Nanocarrier-Based Vaccine Sales and Growth Rate (Kilotons)
Figure 50. South America Nanocarrier-Based Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Nanocarrier-Based Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Nanocarrier-Based Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Nanocarrier-Based Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Nanocarrier-Based Vaccine Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Nanocarrier-Based Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Nanocarrier-Based Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Nanocarrier-Based Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Nanocarrier-Based Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Nanocarrier-Based Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Nanocarrier-Based Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Nanocarrier-Based Vaccine Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Nanocarrier-Based Vaccine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Nanocarrier-Based Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Nanocarrier-Based Vaccine Market Share Forecast by Type (2025-2030)
Figure 65. Global Nanocarrier-Based Vaccine Sales Forecast by Application (2025-2030)
Figure 66. Global Nanocarrier-Based Vaccine Market Share Forecast by Application (2025-2030)
Industry Market Size
